{
  "docId": "019de072-a7a0-747e-aa25-0c712080af8d",
  "docSlug": "2284d180d89eee1cbed73b6e3ca03fc3",
  "documentTitle": "BioAtla | Results Presentation Deck | 9 slides",
  "authorId": "bioatla",
  "authorName": "BioAtla",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 9,
  "prevPage": 8,
  "nextPage": null,
  "slideType": "problem_statement",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "The slide uses a comparative layout to highlight patient population sizes and survival rates across different cancer indications.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-a7a0-747e-aa25-0c712080af8d/9",
  "deckHref": "/decks/019de072-a7a0-747e-aa25-0c712080af8d",
  "deckJsonHref": "/decks/019de072-a7a0-747e-aa25-0c712080af8d.json",
  "deckAnchorHref": "/decks/019de072-a7a0-747e-aa25-0c712080af8d#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.23,
        "x": 0.75,
        "y": 0.35
      },
      "kind": "list",
      "text": "Head & Neck: ~66K newly diagnosed cases / yr (US); 5-year survival rate (~40% for recurrent or advanced metastatic disease); Deficit of 2nd line treatments",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c20284e-cf94-4005-a136-6f8e269ccb6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.23,
        "x": 0.27,
        "y": 0.35
      },
      "kind": "list",
      "text": "NSCLC: ~200K newly diagnosed NSCLC patients / yr (US); 5-year survival rate (~25% for advanced metastatic disease); lack of efficacious therapies for refractory patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89c85bdf-b7e5-40eb-975b-6e2a11f23f96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.23,
        "x": 0.03,
        "y": 0.35
      },
      "kind": "list",
      "text": "Sarcoma: ~17K newly diagnosed metastatic cases / yr (US); 5-year survival rate (~20% for advanced metastatic disease); UPS is one of the largest and most aggressive sarcoma subtypes; Osteosarcoma represents nearly 1/3 of all bone sarcoma cases",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a978f3c1-0d38-4b66-89f6-3dbba22c3055",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.23,
        "x": 0.51,
        "y": 0.35
      },
      "kind": "list",
      "text": "Melanoma: ~200K newly diagnosed cases / yr (US) – 50% invasive; 5-year survival rate (~25% for advanced metastatic disease); ~1.3mm people in the US living with melanoma",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d811b6d4-4aba-4e99-8238-4ee9e143b65a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Sources: www.cancer.net; www.cancer.org; Clarivate, Disease Landscape and Forecast: NSCLC, Melanoma, SCCHN (2022)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34cdad52-83f2-4e05-b581-0d97c5355fc8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Significant Unmet Need and Commercial Opportunity Across Multiple Solid Tumors Types",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2b6ac46-dcf1-4685-b7b2-97ed6731e87f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 9,
      "beatId": "36ad541d-7fcc-4a8b-ab9c-435c589fa4ba",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slide 9: Significant Unmet Need and Commercial Opportunity Across Multiple Solid Tumors Types",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    },
    {
      "to": 9,
      "from": 9,
      "beatId": "92e95ce7-577c-4a42-ab7f-ff997038854f",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slide 9: Significant Unmet Need and Commercial Opportunity Across Multiple Solid Tumors Types",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "9ab52cca-1bcc-467d-abbb-6b8979646ac5",
      "evidence": "Slide 9: Significant Unmet Need and Commercial Opportunity Across Multiple Solid Tumors Types",
      "position": 0,
      "objective": "Highlighting the cost of inaction in addressing unmet medical needs",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}